Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

Summary

This was a Phase I, single-center, randomized, double-blind, placebo-controlled, ascending multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of orally administered EDP-322 in healthy adult volunteers.

Timeline

Start

2008-11

Primary completion

2009-03

Completion

2009-09

Drugs

Indications